Debt Obligations and Commitments

In the first quarter of 2013, we issued:


•	$625 million of floating rate notes maturing in February 2016, which bear interest at a rate equal to the three-month London Inter-Bank Offered Rate (LIBOR) plus 21 basis points;


•	$625 million of 0.700% senior notes maturing in February 2016; and


•	$1.250 billion of 2.750% senior notes maturing in March 2023.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.

In the second quarter of 2013, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement) which expires on June 10, 2018. Subsequent to the end of the second quarter, we increased commitments under this agreement. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $2.925 billion, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $3.5 billion. Additionally, we may, once a year, request renewal of the agreement for an additional one-year period.

Also, in the second quarter of 2013, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement) which expires on June 9, 2014. Subsequent to the end of the second quarter, we increased commitments under this agreement. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $2.925 billion, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $3.5 billion. We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which would mature no later than the then effective termination date.

The Five-Year Credit Agreement and the 2013 364-Day Credit Agreement together replaced our $2.925 billion Four-Year Credit Agreement dated as of June 14, 2011 and our $2.925 billion 364-Day Credit Agreement dated as of June 14, 2011. Funds borrowed under the Five-Year Credit Agreement and the 2013 364-Day Credit Agreement may be used for general corporate purposes of PepsiCo and our subsidiaries.

As of June 15, 2013, we had $2.4 billion of commercial paper outstanding.

Long-Term Contractual Commitments ^(a)



	Payments Due by Period
	Total		2013		2014 – 2015		2016 – 2017		2018 and beyond
Long-term debt obligations ^(b)	$	22,681	$	—	$	3,792	$	4,355	$	14,534
Interest on debt obligations ^(c)	8,698		511		1,560		1,321		5,306
Operating leases	1,993		256		700		396		641
Purchasing commitments ^(d)	1,959		449		1,082		208		220
Marketing commitments ^(d)	2,245		163		630		492		960
	$	37,576	$	1,379	$	7,764	$	6,772	$	21,661


(a)	Based on quarter-end foreign exchange rates.


(b)	Excludes $3,656 million related to current maturities of long-term debt, $273 million related to the increase in carrying value of long-term debt reflecting the gains on our fair value interest rate swaps and $258 million related to the fair value step-up of debt acquired in connection with our acquisitions of The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) in February 2010.


(c)	Interest payments on floating-rate debt are estimated using interest rates effective as of June 15, 2013.


(d)	Primarily reflects non-cancelable commitments as of June 15, 2013.

Most long-term contractual commitments, except for our long-term debt obligations, are not recorded on our balance sheet. Operating leases primarily represent building leases. Non-cancelable purchasing commitments are primarily for packaging materials and oranges and orange juice. Non-cancelable marketing commitments are primarily for sports marketing. Bottler funding to independent bottlers is not reflected in our long-term contractual commitments as it is negotiated on an annual basis. Accrued liabilities for pension and retiree medical plans are not reflected in our long-term contractual commitments because they do not represent expected future cash outflows. See Note 7 for additional information regarding our pension and retiree medical obligations.